RE:RE:RE:RE:NewsIn reading the release I thought the information was positive and I have been here for over 8 years. I thought the pre meeting with the FDA was a success as all their questions were answered (assuming they asked the right ones) and they are still on target for submission. That alone is a plus considering the previous management was never on time or on budget for anything. The "mock audit" mentioned it was detailed which likely resulted in feedback, suggestions, corrective actions for improvement to get ready for the real FDA audit. So reading between the lines I assumed this was also positive. It seems to me that this group is doing things right and have a roadmap for success, hopefully it turns out that way.
You cannot tell based on the current price so close to submission. The price is inconceivable at this stage, even for a risky stock, and besides that who is selling at these levels with so many positive items only a short time away.